Back to top

Analyst Blog

Covidien plc (COV - Analyst Report) revealed that the American College of Chest Physicians (ACCP) has included the company’s superDimension Electromagnetic Navigation Bronchoscopy (ENB) system in its guidelines for early detection and diagnosis of lung cancer.

With hardly any signs of symptoms at an early stage, lung cancer usually goes undetected for a prolonged period of time. This makes lung cancer the leading cause of death in the U.S. Lung cancer, if detected and treated at an early stage, can significantly increase long-term survival rate.

The one-of-a-kind ENB system is an effective and safe diagnostic platform for early detection of lung cancer. It became part of Covidien’s Endomechanical product portfolio with the acquisition of superDimension in 2012. The advanced technology of the system can access difficult areas of the lungs to collect tissue sample of lesions, which is usually unattainable by conventional bronchoscopes. Moreover, its minimally invasive technology is less morbid in comparison to more invasive procedures.

Covidien is a leading global health care products company with a history of developing high-quality products in a cost-effective manner. The incorporation of the ENB system in the ACCP guidelines further reinstates this commitment by the company.

However, the company recently provided a dismal fiscal 2013 guidance, which complements its Zacks Rank #5 (Strong Sell). Further, uncertainty regarding divestment of the Pharmaceutical unit at the end of Jun 2013 keeps us on the sidelines.

While we strongly recommend investors to avoid this stock, other medical stocks such as Conceptus , Atricure (ATRC - Snapshot Report) and Myriad Genetics (MYGN - Analyst Report) warrant a look. All the stocks carry a Zacks Rank #2 (Buy).
 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
RPC INC RES 24.91 +8.35%
LITHIA MOTO… LAD 94.59 +4.60%
DELTA AIR L… DAL 39.15 +3.90%
FLAMEL TECH… FLML 14.51 +3.50%
SOUTHWEST A… LUV 28.87 +2.92%